All In Biotech

Drug Trial Radar · NCT06469853

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients

A Phase IIa, Open Label, Single Centre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Orally Dosed MBF-015 in Huntington's Disease Patients

Last checked: Nov 19, 2026Latest source record: Mar 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Feb 1, 2024

Primary completion

Dec 4, 2024

Study completion Dec 4, 2024

Sponsor

Lead sponsor
Medibiofarma S.L.Industry
Sponsor type
Industry
First posted
Jun 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 25 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase IIa (proof of concept), single center clinical trial to evaluate the safety and efficacy of daily MBF-015 oral treatment during 28 days in Huntington's Disease patients on top of standard of care.

Conditions

  • Huntington Disease

Interventions

  • MBF-015 16 mg oral capsulesDrug

    MBF-015 oral capsules HDAC inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: 43 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    Barcelona, Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.